Synergistic Effects of A Combined Treatment of Glioblastoma U251 Cells with An Anti-miR-10b-5p Molecule and An AntiCancer Agent Based on 1-(3′,4′,5′-Trimethoxyphenyl)-2-Aryl-1H-Imidazole Scaffold

Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway

(2022) Peng Xu et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Treatment of Human Glioblastoma U251 Cells with Sulforaphane and a Peptide Nucleic Acid (PNA) Targeting miR-15b-5p: Synergistic Effects on Induction of Apoptosis

(2022) Jessica Gasparello et al.   MOLECULES

Cytoskeletal proteins as glioblastoma biomarkers and targets for therapy: a systematic review

(2021) Alja Zottel et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Synergistic effects of the combined treatment of U251 and T98G glioma cells with an anti‑tubulin tetrahydrothieno[2,3‑c]pyridine derivative and a peptide nucleic acid targeting miR‑221‑3p

(2021) Matteo Zurlo et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Discovery of novel trimethoxyphenylbenzo[d]oxazoles as dual tubulin/PDE4 inhibitors capable of inducing apoptosis at G2/M phase arrest in glioma and lung cancer cells

(2021) Jie liu et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study

(2021) Suresh S. Ramalingam et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy and Safety of Bevacizumab Combined with Other Therapeutic Regimens for Treatment of Recurrent Glioblastoma: A Network Meta-analysis

(2021) Su Dongpo et al.   World Neurosurgery

Combining an Autophagy Inhibitor, MPT0L145, with Abemaciclib Is a New Therapeutic Strategy in GBM Treatment

(2021) Tsung-Han Hsieh et al.   Cancers

Synergistic Anticancer Effect of Glycolysis and Histone Deacetylases Inhibitors in a Glioblastoma Model

(2021) Beata Pająk et al.   Biomedicines

Design, synthesis, biological evaluation and molecular docking studies of new chalcone derivatives containing diaryl ether moiety as potential anticancer agents and tubulin polymerization inhibitors

(2020) Guangcheng Wang et al.   BIOORGANIC CHEMISTRY

High Levels of Apoptosis Are Induced in the Human Colon Cancer HT-29 Cell Line by Co-Administration of Sulforaphane and a Peptide Nucleic Acid Targeting miR-15b-5p

(2020) Jessica Gasparello et al.   Nucleic Acid Therapeutics

Synthesis and Biological Evaluation of New Antitubulin Agents Containing 2-(3′,4′,5′-trimethoxyanilino)-3,6-disubstituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine Scaffold

(2020) Romeo Romagnoli et al.   MOLECULES

Simultaneous delivery of anti-miRNA and docetaxel with supramolecular self-assembled “chitosome” for improving chemosensitivity of triple negative breast cancer cells

(2020) Xianfu Sun et al.   Drug Delivery and Translational Research

Anti-tubulin agent vinorelbine inhibits metastasis of cancer cells by regulating epithelial-mesenchymal transition

(2020) Hongyu Liu et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Combinatory Treatment with miR-7-5p and Drug-Loaded Cubosomes Effectively Impairs Cancer Cells

(2020) Ewa Gajda et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

A Molecular Signature associated with prolonged survival in Glioblastoma patients treated with Regorafenib

(2020) Alessandra Santangelo et al.   NEURO-ONCOLOGY

High-throughput microRNA profile in adult and pediatric primary glioblastomas: the role of miR-10b-5p and miR-630 in the tumor aggressiveness

(2020) Luiz Guilherme Darrigo Junior et al.   MOLECULAR BIOLOGY REPORTS

Interaction of BACH2 with FUS promotes malignant progression of glioma cells via the TSLNC8–miR‐10b‐5p–WWC3 pathway

(2020) Yang Yang et al.   Molecular Oncology

The effect of combined miR‐200c replacement and cisplatin on apoptosis induction and inhibition of gastric cancer cell line migration

(2019) Mehri Ghasabi et al.   JOURNAL OF CELLULAR PHYSIOLOGY

MicroRNA‑10b‑5p downregulation inhibits the invasion of glioma cells via modulating homeobox B3 expression

(2019) Weiling Li et al.   Experimental and Therapeutic Medicine

Enhanced Inhibition of Tumorigenesis Using Combinations of miRNA-Targeted Therapeutics

(2019) Svetlana Miroshnichenko et al.   Frontiers in Pharmacology

Noscapine, a Non-addictive Opioid and Microtubule-Inhibitor in Potential Treatment of Glioblastoma

(2019) Meric A. Altinoz et al.   NEUROCHEMICAL RESEARCH

Stepwise detection and evaluation reveal miR-10b and miR-222 as a remarkable prognostic pair for glioblastoma

(2019) Bo Sun et al.   ONCOGENE

Novel [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potent antitubulin agents: Design, multicomponent synthesis and antiproliferative activities

(2019) Fang Yang et al.   BIOORGANIC CHEMISTRY

MicroRNA-10b mediates TGF-β1-regulated glioblastoma proliferation, migration and epithelial-mesenchymal transition

(2017) Chengyuan Ma et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

MiR-424 functions as a tumor suppressor in glioma cells and is down-regulated by DNA methylation

(2017) Chen Jin et al.   JOURNAL OF NEURO-ONCOLOGY

European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma

(2017) Andrea Pace et al.   LANCET ONCOLOGY

Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b

(2017) Rachid El Fatimy et al.   MOLECULAR THERAPY

Development and Biological Evaluation of a Photoactivatable Small Molecule Microtubule-Targeting Agent

(2017) Alexander Döbber et al.   ACS Medicinal Chemistry Letters

Combination therapy in combating cancer

(2017) Reza Bayat Mokhtari et al.   Oncotarget

Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic

(2016) N. M. Teplyuk et al.   EMBO Molecular Medicine

Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: New trends in the development of miRNA therapeutic strategies in oncology (Review)

(2016) ROBERTO GAMBARI et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Tailored Nanoparticle Codelivery of antimiR-21 and antimiR-10b Augments Glioblastoma Cell Kill by Temozolomide: Toward a “Personalized” Anti-microRNA Therapy

(2016) Jeyarama S. Ananta et al.   MOLECULAR PHARMACEUTICS

MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9

(2016) Nan Liu et al.   Oncotarget

Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3′,4′,5′-Trimethoxyphenyl)-2-Aryl-1H-Imidazole

(2016) Romeo Romagnoli et al.   Scientific Reports

Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs

(2015) C von Neubeck et al.   BRITISH JOURNAL OF RADIOLOGY

MicroRNA-10b inhibition reduces E2F1-mediated transcription and miR-15/16 activity in glioblastoma

(2015) Nadiya M. Teplyuk et al.   Oncotarget

Pathology, Molecular Genetics, and Epigenetics of Diffuse Intrinsic Pontine Glioma

(2015) Pawel Buczkowicz et al.   Frontiers in Oncology

Hypoxia-inducible factor-2α (HIF-2α), but not HIF-1α, is essential for hypoxic induction of class III β-tubulin expression in human glioblastoma cells

(2014) Karim Bordji et al.   FEBS Journal

Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221

(2014) Eleonora Brognara et al.   JOURNAL OF NEURO-ONCOLOGY

U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells

(2014) Anja Torsvik et al.   Cancer Medicine

Oncogenic effects of miR-10b in glioblastoma stem cells

(2013) Fadila Guessous et al.   JOURNAL OF NEURO-ONCOLOGY

Tubulins as Therapeutic Targets in Cancer: from Bench to Bedside

(2012) Christos D. Katsetos et al.   CURRENT PHARMACEUTICAL DESIGN

Co-inhibition of microRNA-10b and microRNA-21 exerts synergistic inhibition on the proliferation and invasion of human glioma cells

(2012) CHANG G. DONG et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

MicroRNA-10b pleiotropically regulates invasion, angiogenicity and apoptosis of tumor cells resembling mesenchymal subtype of glioblastoma multiforme

(2012) J Lin et al.   Cell Death & Disease

Human Glioma Growth Is Controlled by MicroRNA-10b

(2011) G. Gabriely et al.   CANCER RESEARCH

MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC

(2009) Takashi Sasayama et al.   INTERNATIONAL JOURNAL OF CANCER